Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer
暂无分享,去创建一个
V. Franceschi | G. Donofrio | L. Conti | F. Macchi | L. Russo | F. Cavallo | Elisabetta Bolli | F. Riccardo | E. Quaglino | Antonino Di Lorenzo | R. Ruiu | Roberto Ruiu